Active Ingredient(s):Flunisolide FDA Approved: * August 17, 1984 Pharm Company: *ROCHE PALO Category:Asthma
Flunisolide (marketed as AeroBid among others) is a corticosteroid often prescribed as treatment for allergic rhinitis. Intranasal corticosteroids are the most effective medication for controlling symptoms. 
The principal mechanism of action of flunisolide is to activate glucocorticoid receptors, meaning it has an anti-inflammatory action. The effects of topical corticosteroids is not immediate and requires regular use and at least a few days to start exp...
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions